Folate Analog Metabolic Inhibitor [EPC]

278808 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 46332
1 RHEUMATOID ARTHRITIS 23474
2 ARTHRALGIA 20850
3 PAIN 18724
4 NAUSEA 15026
5 FATIGUE 14676
6 INJECTION SITE PAIN 12634
7 OFF LABEL USE 12300
8 HEADACHE 12169
9 JOINT SWELLING 11754
See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 252 0.8780
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 700 0.8028
2 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1101 0.7058
3 RHEUMATOID FACTOR POSITIVE 1010 0.6738
4 C-REACTIVE PROTEIN ABNORMAL 1673 0.6571
5 SYNOVITIS 4618 0.5837
6 PEMPHIGUS 1488 0.5333
7 GRANULOMA SKIN 227 0.5255
8 BODY HEIGHT BELOW NORMAL 291 0.4932
9 RHEUMATOID NODULE 884 0.4879
See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]